Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent E Wallner

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Oncology (Williston Park, N.Y.)|January 9, 2008
Technologic evolution in the treatment of prostate cancer. Clinical, financial, and legal implications for managed care organizationsTony S Quang, Kent E Wallner, Paul R Herstein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
Intraoperative fluoroscopic dose assessment in prostate brachytherapy patientsDaniel R Reed, Kent E Wallner, Sreeram Narayanan, et al.
Brachytherapy|November 23, 2006
Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarctionAlan X Zhu, Kent E Wallner, Geir P Frivold, et al.
Brachytherapy|November 10, 2007
The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapyNathan Bittner, Gregory S Merrick, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urology|December 20, 2005
Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidityMegan Beekman, Gregory S Merrick, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external-beam radiationGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urology|November 16, 2005
Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urologic Nursing|October 18, 2005
Nursing considerations in brachytherapy-related erectile dysfunctionRobin Stipetich, Laura J Abel, Richard L Anderson, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Oncology (Williston Park, N.Y.)|January 9, 2008
Technologic evolution in the treatment of prostate cancer. Clinical, financial, and legal implications for managed care organizationsTony S Quang, Kent E Wallner, Paul R Herstein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
Intraoperative fluoroscopic dose assessment in prostate brachytherapy patientsDaniel R Reed, Kent E Wallner, Sreeram Narayanan, et al.
Brachytherapy|November 23, 2006
Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarctionAlan X Zhu, Kent E Wallner, Geir P Frivold, et al.
Brachytherapy|November 10, 2007
The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapyNathan Bittner, Gregory S Merrick, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urology|December 20, 2005
Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidityMegan Beekman, Gregory S Merrick, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external-beam radiationGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urology|November 16, 2005
Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urologic Nursing|October 18, 2005
Nursing considerations in brachytherapy-related erectile dysfunctionRobin Stipetich, Laura J Abel, Richard L Anderson, et al.
Pageof 12